MedPath

Periconceptional Iron Supplementation in Rural Bangladesh

Early Phase 1
Completed
Conditions
Anemia
Interventions
Dietary Supplement: Ferrous fumarate (iron)
Dietary Supplement: folic acid
Registration Number
NCT00953134
Lead Sponsor
The Hospital for Sick Children
Brief Summary

The investigators hypothesize that periconceptional iron supplementation to married, nulliparous women in rural Bangladesh will significantly reduce anemia and improve hemoglobin concentrations before and during pregnancy.

Detailed Description

In 2007, the National Strategy for Anemia Prevention and Control in Bangladesh included adolescents and newly married women as target groups for future iron and folic acid (IFA) supplementation programs. This double-blinded RCT examined the effect of daily periconceptional IFA vs. folic acid (FA) on anemia and iron indictors before and during pregnancy among married, nulliparous women in rural Bangladesh. Biochemical indices were collected at baseline and either at 15 weeks gestation or after 9 months among non-pregnant women (NPW).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
273
Inclusion Criteria

Women were eligible if they were:

  • Married
  • Nulliparous
  • < 40 years old
  • Living in the same household as their husband
Exclusion Criteria

Women were excluded if they were:

  • Pregnant at enrollment
  • Planning to move out of the region
  • Using iron supplements within the previous 3 months
  • Using an implant form of birth control, or had surgery to prevent pregnancy
  • Women with a Hb concentration of < 70 g/L, defined as severely anemic according to WHO definition (5), were excluded from the study and appropriately treated

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1folic acidIFA - Iron and Folic Acid (60 mg of ferrous fumarate and 400 mcg folic acid)
2folic acidFA - Folic Acid (400 mcg folic acid)
1Ferrous fumarate (iron)IFA - Iron and Folic Acid (60 mg of ferrous fumarate and 400 mcg folic acid)
Primary Outcome Measures
NameTimeMethod
HemoglobinFebruary 2007-February 2008
Secondary Outcome Measures
NameTimeMethod
Plasma ferritinFebruary 2007-February 2008

Trial Locations

Locations (1)

Brac

🇧🇩

Dhaka, Dhaka Division, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath